Lung interstitial natural killer cells in patients with lung cancer: presence, activity and response to interleukin-2
- 30 September 1989
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 5 (2-3) , 41-48
- https://doi.org/10.1016/0169-5002(89)90001-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cellsCellular Immunology, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.The Journal of Immunology, 1985
- Modulation of human natural killer cell activity by recombinant human interleukin 2Cellular Immunology, 1985
- Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.The Journal of Immunology, 1985
- Natural killer cells are present in the normal human lung but are functionally impotent.Journal of Clinical Investigation, 1984
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984
- The biology of the human natural killer cellJournal of Clinical Immunology, 1982
- Interleukin-2 augments natural killer cell activityNature, 1981